Biotech industry kills another cancer patient in experimental drug study

‘Despite the growing body of evidence proving that natural cancer treatments are more effective than those involving dangerous pharmaceuticals, the cancer industry continues killing patients in its reckless pursuit of profits – as evidenced by the latest death which occurred during clinical trials of an experimental drug made by biotech company Ziopharm Oncology Inc.
A patient suffering from a recurrent brain tumor died from bleeding in the skull shortly after beginning treatment with the Ziopharm gene therapy drug known as Ad-RTS-hIL-12.
The drug is designed to be injected directly into a tumor, theoretically producing a tumor-shrinking autoimmune response, but the patient in question instead suffered from an intracranial hemorrhage 15 days after receiving the Ad-RTS-hIL-12 injection.’
Read more: Biotech industry kills another cancer patient in experimental drug study